Results 41 to 50 of about 9,207 (164)

[Nimesil treatment of gouty arthritis].

open access: yesTerapevticheskii arkhiv, 2003
To evaluate efficacy and safety of nimesil, a selective inhibitor of cyclooxigenase-2, in gouty arthritis (GA).Nimesil was given to 20 male patients with GA (mean age 53.8 years, mean duration of the disease 8.1 years) in a dose 100 mg twice a day for 14 or 21 days depending on positive clinical changes (13 and 6 patients, respectively).
V G Barskova, I A Yakunina, V A Nasonova
openaire   +3 more sources

Chinese Expert Consensus on Perioperative Management of Gouty Arthritis(2025)

open access: yesXiehe Yixue Zazhi
Patients with gouty arthritis may encounter a range of perioperative challenges in orthopedic settings, including acute gout flares and infectious complications, which not only compromise patient well-being but may also adversely affect surgical outcomes
Joint Surgery Group of the Orthopedic Society of the Chinese Medical Association
doaj   +1 more source

Acute gouty arthritis following percutaneous cryoablation of renal cell carcinoma

open access: yesRadiology Case Reports, 2019
We report a case of acute gouty monoarthritis of the left ankle in a 58-year-old female with chronic renal insufficiency after cryoablation of a 3.8 cm left renal cell carcinoma.
Ahmed-Zayn Mohamed, JD   +4 more
doaj   +1 more source

The X-rays in Gouty Arthritis [PDF]

open access: yesThe American Journal of the Medical Sciences, 1914
n ...
openaire   +1 more source

Procalcitonin may not be a differential diagnostic marker for bacterial infection in febrile patients with chronic gouty arthritis

open access: yesJournal of International Medical Research, 2018
Objective This study aimed to examine the diagnostic value of serum procalcitonin (PCT) levels for identifying bacterial infection in febrile patients with chronic gouty arthritis.
Jing Zhang   +7 more
doaj   +1 more source

Advances in the study of gut microecology and mechanisms of hyperuricemia and gouty arthritis

open access: yesFrontiers in Immunology
Gouty arthritis is a metabolic disorder caused by purine metabolism dysregulation, characterized by monosodium urate crystal deposition in and around joints, triggering acute articular inflammation via NLRP3 inflammasome activation and IL-1β-mediated ...
Youliang Zhang   +15 more
doaj   +1 more source

Treat to target in gouty arthritis [PDF]

open access: yesVnitřní lékařství, 2018
Gout is a crystal-induced, metabolically determined inflammatory rheumatic disease with increasing prevalence. In clinical practice, gout causes frequent diagnostic as well as therapeutic problems. The golden diagnostic standard is crystalographic analysis and evidence of monosodium urate crystals in the polarization microscope; if this is not ...
openaire   +2 more sources

Upadacitinib sustained-release tablets for the treatment of chronic refractory gouty arthritis: a case report and literature review

open access: yesFrontiers in Medicine
BackgroundGouty arthritis (GA) is a crystal-related joint disease caused by the deposition of monosodium urate (MSU) crystals, directly associated with hyperuricemia resulting from purine metabolism disorder and/or reduced uric acid excretion.
Lishi Yu   +4 more
doaj   +1 more source

ETHORICOXIB IN THE TREATMENT OF RHEUMATIC DISEASES

open access: yesСовременная ревматология, 2010
Ethoricoxib is a new-generation selective COX-2 inhibitor. It has been recently licensed in Russia for the treatment of osteoarthrosis (OA), rheumatoid arthritis (RA), ankylosing spondylitis (AS), and acute gouty arthritis.
Yu A Olyunin, Yu A Olyunin
doaj   +1 more source

Alterations in articular cartilage frictional properties in the setting of acute gouty arthritis.

open access: yesPLoS ONE
The tribological behaviour of articular cartilage plays a key role in joint motion; however, there is a gap in research on the effect of hyperuricemic joint fluid on cartilage friction behaviour in acute gouty arthritis.
Pai Zheng   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy